nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2C9—brain cancer	0.503	1	CbGaD
Bupropion—CYP2D6—Lomustine—brain cancer	0.0549	0.183	CbGbCtD
Bupropion—CYP1A2—Carmustine—brain cancer	0.0543	0.181	CbGbCtD
Bupropion—CYP2D6—Hydroxyurea—brain cancer	0.0416	0.139	CbGbCtD
Bupropion—CYP3A4—Temozolomide—brain cancer	0.0411	0.137	CbGbCtD
Bupropion—CYP3A4—Lomustine—brain cancer	0.0349	0.116	CbGbCtD
Bupropion—CYP2E1—Etoposide—brain cancer	0.0279	0.0928	CbGbCtD
Bupropion—CYP2C8—Etoposide—brain cancer	0.0208	0.0693	CbGbCtD
Bupropion—CYP1A2—Etoposide—brain cancer	0.0161	0.0537	CbGbCtD
Bupropion—CYP3A4—Etoposide—brain cancer	0.00844	0.0281	CbGbCtD
Bupropion—SLC6A3—telencephalic ventricle—brain cancer	0.00207	0.104	CbGeAlD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—OTX2—brain cancer	0.00149	0.0453	CbGpPWpGaD
Bupropion—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00142	0.0432	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—CYP2C9—brain cancer	0.0014	0.0424	CbGpPWpGaD
Bupropion—SLC6A3—ganglion—brain cancer	0.00129	0.0645	CbGeAlD
Bupropion—CYP2C8—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00126	0.0381	CbGpPWpGaD
Bupropion—CYP2B6—CYP2E1 reactions—CYP2C9—brain cancer	0.00115	0.0348	CbGpPWpGaD
Bupropion—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00114	0.0346	CbGpPWpGaD
Bupropion—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00113	0.0341	CbGpPWpGaD
Bupropion—SLC6A2—ganglion—brain cancer	0.00104	0.052	CbGeAlD
Bupropion—SLC6A3—hindbrain—brain cancer	0.000977	0.0489	CbGeAlD
Bupropion—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.000973	0.0295	CbGpPWpGaD
Bupropion—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.000883	0.0268	CbGpPWpGaD
Bupropion—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.000873	0.0265	CbGpPWpGaD
Bupropion—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000849	0.0257	CbGpPWpGaD
Bupropion—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.000799	0.0242	CbGpPWpGaD
Bupropion—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.000794	0.0241	CbGpPWpGaD
Bupropion—CYP2B6—Xenobiotics—CYP2C9—brain cancer	0.000712	0.0216	CbGpPWpGaD
Bupropion—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.000698	0.0212	CbGpPWpGaD
Bupropion—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.000671	0.0203	CbGpPWpGaD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—GLI2—brain cancer	0.00065	0.0197	CbGpPWpGaD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—GLI1—brain cancer	0.000611	0.0185	CbGpPWpGaD
Bupropion—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000606	0.0184	CbGpPWpGaD
Bupropion—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.000603	0.0183	CbGpPWpGaD
Bupropion—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00058	0.0176	CbGpPWpGaD
Bupropion—CHRNA3—endocrine gland—brain cancer	0.000567	0.0284	CbGeAlD
Bupropion—SLC6A3—brainstem—brain cancer	0.00056	0.028	CbGeAlD
Bupropion—CHRNA3—head—brain cancer	0.00056	0.028	CbGeAlD
Bupropion—CHRNA3—central nervous system—brain cancer	0.000511	0.0256	CbGeAlD
Bupropion—CHRNA3—cerebellum—brain cancer	0.0005	0.025	CbGeAlD
Bupropion—SLC6A3—telencephalon—brain cancer	0.000497	0.0249	CbGeAlD
Bupropion—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.000495	0.015	CbGpPWpGaD
Bupropion—CYP2B6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000489	0.0148	CbGpPWpGaD
Bupropion—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.000476	0.0144	CbGpPWpGaD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000466	0.0141	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000456	0.0138	CbGpPWpGaD
Bupropion—SLC6A2—brainstem—brain cancer	0.000452	0.0226	CbGeAlD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—SHH—brain cancer	0.000442	0.0134	CbGpPWpGaD
Bupropion—CYP2D6—hindbrain—brain cancer	0.000432	0.0216	CbGeAlD
Bupropion—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000419	0.0127	CbGpPWpGaD
Bupropion—CHRNA3—brain—brain cancer	0.000406	0.0203	CbGeAlD
Bupropion—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000403	0.0122	CbGpPWpGaD
Bupropion—SLC6A2—telencephalon—brain cancer	0.000401	0.0201	CbGeAlD
Bupropion—ORM1—spinal cord—brain cancer	0.000375	0.0187	CbGeAlD
Bupropion—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000367	0.0111	CbGpPWpGaD
Bupropion—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000362	0.011	CbGpPWpGaD
Bupropion—SLC6A3—midbrain—brain cancer	0.000357	0.0179	CbGeAlD
Bupropion—SLC6A3—spinal cord—brain cancer	0.000348	0.0174	CbGeAlD
Bupropion—ORM1—endocrine gland—brain cancer	0.000337	0.0169	CbGeAlD
Bupropion—SLC6A2—gonad—brain cancer	0.000335	0.0168	CbGeAlD
Bupropion—CYP2A6—cerebellum—brain cancer	0.000326	0.0163	CbGeAlD
Bupropion—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000324	0.00982	CbGpPWpGaD
Bupropion—SLC6A2—medulla oblongata—brain cancer	0.000315	0.0158	CbGeAlD
Bupropion—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000311	0.00944	CbGpPWpGaD
Bupropion—SLC6A3—head—brain cancer	0.00031	0.0155	CbGeAlD
Bupropion—ORM1—central nervous system—brain cancer	0.000304	0.0152	CbGeAlD
Bupropion—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000297	0.00901	CbGpPWpGaD
Bupropion—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000296	0.00897	CbGpPWpGaD
Bupropion—CYP2B6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000292	0.00885	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00029	0.00879	CbGpPWpGaD
Bupropion—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00029	0.00879	CbGpPWpGaD
Bupropion—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000286	0.00867	CbGpPWpGaD
Bupropion—SLC6A3—central nervous system—brain cancer	0.000283	0.0141	CbGeAlD
Bupropion—CYP2E1—telencephalon—brain cancer	0.000277	0.0139	CbGeAlD
Bupropion—SLC6A3—cerebellum—brain cancer	0.000276	0.0138	CbGeAlD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000274	0.00832	CbGpPWpGaD
Bupropion—CYP2C8—pituitary gland—brain cancer	0.000268	0.0134	CbGeAlD
Bupropion—CYP2A6—brain—brain cancer	0.000265	0.0133	CbGeAlD
Bupropion—SLC6A2—endocrine gland—brain cancer	0.000253	0.0127	CbGeAlD
Bupropion—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00025	0.00759	CbGpPWpGaD
Bupropion—SLC6A2—head—brain cancer	0.00025	0.0125	CbGeAlD
Bupropion—CYP2D6—brainstem—brain cancer	0.000247	0.0124	CbGeAlD
Bupropion—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000247	0.00749	CbGpPWpGaD
Bupropion—CYP2B6—gonad—brain cancer	0.000247	0.0123	CbGeAlD
Bupropion—CYP2B6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00024	0.00727	CbGpPWpGaD
Bupropion—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000235	0.00712	CbGpPWpGaD
Bupropion—SLC6A3—Parkinsons Disease Pathway—CCNE1—brain cancer	0.000233	0.00705	CbGpPWpGaD
Bupropion—SLC6A2—central nervous system—brain cancer	0.000228	0.0114	CbGeAlD
Bupropion—SLC6A3—brain—brain cancer	0.000224	0.0112	CbGeAlD
Bupropion—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000222	0.00674	CbGpPWpGaD
Bupropion—CYP2D6—telencephalon—brain cancer	0.00022	0.011	CbGeAlD
Bupropion—CYP2E1—medulla oblongata—brain cancer	0.000218	0.0109	CbGeAlD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000212	0.00642	CbGpPWpGaD
Bupropion—CYP2C8—endocrine gland—brain cancer	0.000208	0.0104	CbGeAlD
Bupropion—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000206	0.00623	CbGpPWpGaD
Bupropion—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000203	0.00616	CbGpPWpGaD
Bupropion—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000203	0.00615	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000201	0.00611	CbGpPWpGaD
Bupropion—Hypoaesthesia—Carmustine—brain cancer	0.000201	0.0014	CcSEcCtD
Bupropion—Decreased appetite—Procarbazine—brain cancer	0.000199	0.00139	CcSEcCtD
Bupropion—Oedema peripheral—Carmustine—brain cancer	0.000199	0.00138	CcSEcCtD
Bupropion—Connective tissue disorder—Carmustine—brain cancer	0.000198	0.00138	CcSEcCtD
Bupropion—Fatigue—Procarbazine—brain cancer	0.000198	0.00137	CcSEcCtD
Bupropion—Haemoglobin—Temozolomide—brain cancer	0.000196	0.00136	CcSEcCtD
Bupropion—Malaise—Hydroxyurea—brain cancer	0.000196	0.00136	CcSEcCtD
Bupropion—Constipation—Procarbazine—brain cancer	0.000196	0.00136	CcSEcCtD
Bupropion—Pain—Procarbazine—brain cancer	0.000196	0.00136	CcSEcCtD
Bupropion—Haemorrhage—Temozolomide—brain cancer	0.000195	0.00136	CcSEcCtD
Bupropion—Hepatitis—Temozolomide—brain cancer	0.000195	0.00136	CcSEcCtD
Bupropion—Dysphagia—Etoposide—brain cancer	0.000195	0.00136	CcSEcCtD
Bupropion—Leukopenia—Hydroxyurea—brain cancer	0.000194	0.00135	CcSEcCtD
Bupropion—CYP1A2—endocrine gland—brain cancer	0.000194	0.00973	CbGeAlD
Bupropion—Visual impairment—Carmustine—brain cancer	0.000194	0.00135	CcSEcCtD
Bupropion—CYP2E1—spinal cord—brain cancer	0.000194	0.00973	CbGeAlD
Bupropion—Hypoaesthesia—Temozolomide—brain cancer	0.000194	0.00135	CcSEcCtD
Bupropion—Hallucination—Temozolomide—brain cancer	0.000194	0.00135	CcSEcCtD
Bupropion—Pharyngitis—Temozolomide—brain cancer	0.000194	0.00135	CcSEcCtD
Bupropion—Urinary tract disorder—Temozolomide—brain cancer	0.000193	0.00134	CcSEcCtD
Bupropion—Oedema peripheral—Temozolomide—brain cancer	0.000192	0.00134	CcSEcCtD
Bupropion—Bronchospasm—Etoposide—brain cancer	0.000192	0.00133	CcSEcCtD
Bupropion—Connective tissue disorder—Temozolomide—brain cancer	0.000192	0.00133	CcSEcCtD
Bupropion—Urethral disorder—Temozolomide—brain cancer	0.000191	0.00133	CcSEcCtD
Bupropion—Sweating increased—Etoposide—brain cancer	0.00019	0.00132	CcSEcCtD
Bupropion—Feeling abnormal—Procarbazine—brain cancer	0.000189	0.00131	CcSEcCtD
Bupropion—Eye disorder—Carmustine—brain cancer	0.000189	0.00131	CcSEcCtD
Bupropion—Convulsion—Hydroxyurea—brain cancer	0.000188	0.00131	CcSEcCtD
Bupropion—Visual impairment—Temozolomide—brain cancer	0.000188	0.00131	CcSEcCtD
Bupropion—Gastrointestinal pain—Procarbazine—brain cancer	0.000187	0.0013	CcSEcCtD
Bupropion—Flushing—Carmustine—brain cancer	0.000187	0.0013	CcSEcCtD
Bupropion—CYP2B6—endocrine gland—brain cancer	0.000186	0.00933	CbGeAlD
Bupropion—Pancytopenia—Etoposide—brain cancer	0.000185	0.00129	CcSEcCtD
Bupropion—CYP2C9—endocrine gland—brain cancer	0.000185	0.00924	CbGeAlD
Bupropion—Erythema multiforme—Temozolomide—brain cancer	0.000184	0.00128	CcSEcCtD
Bupropion—CYP2B6—head—brain cancer	0.000184	0.00921	CbGeAlD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000184	0.00128	CcSEcCtD
Bupropion—Discomfort—Hydroxyurea—brain cancer	0.000183	0.00127	CcSEcCtD
Bupropion—Eye disorder—Temozolomide—brain cancer	0.000182	0.00127	CcSEcCtD
Bupropion—Urticaria—Procarbazine—brain cancer	0.000182	0.00127	CcSEcCtD
Bupropion—Tinnitus—Temozolomide—brain cancer	0.000182	0.00127	CcSEcCtD
Bupropion—Abdominal pain—Procarbazine—brain cancer	0.000181	0.00126	CcSEcCtD
Bupropion—Body temperature increased—Procarbazine—brain cancer	0.000181	0.00126	CcSEcCtD
Bupropion—SLC6A2—brain—brain cancer	0.000181	0.00906	CbGeAlD
Bupropion—Cardiac disorder—Temozolomide—brain cancer	0.000181	0.00126	CcSEcCtD
Bupropion—Flushing—Temozolomide—brain cancer	0.000181	0.00126	CcSEcCtD
Bupropion—Arrhythmia—Carmustine—brain cancer	0.00018	0.00125	CcSEcCtD
Bupropion—Alopecia—Carmustine—brain cancer	0.000178	0.00124	CcSEcCtD
Bupropion—Oedema—Hydroxyurea—brain cancer	0.000177	0.00123	CcSEcCtD
Bupropion—Angiopathy—Temozolomide—brain cancer	0.000177	0.00123	CcSEcCtD
Bupropion—Mental disorder—Carmustine—brain cancer	0.000177	0.00123	CcSEcCtD
Bupropion—Infection—Hydroxyurea—brain cancer	0.000176	0.00123	CcSEcCtD
Bupropion—Immune system disorder—Temozolomide—brain cancer	0.000176	0.00123	CcSEcCtD
Bupropion—Mediastinal disorder—Temozolomide—brain cancer	0.000176	0.00122	CcSEcCtD
Bupropion—Malnutrition—Carmustine—brain cancer	0.000176	0.00122	CcSEcCtD
Bupropion—Chills—Temozolomide—brain cancer	0.000175	0.00122	CcSEcCtD
Bupropion—CYP2E1—endocrine gland—brain cancer	0.000175	0.00876	CbGeAlD
Bupropion—Pneumonia—Etoposide—brain cancer	0.000175	0.00122	CcSEcCtD
Bupropion—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000174	0.00528	CbGpPWpGaD
Bupropion—Nervous system disorder—Hydroxyurea—brain cancer	0.000174	0.00121	CcSEcCtD
Bupropion—Infestation NOS—Etoposide—brain cancer	0.000174	0.00121	CcSEcCtD
Bupropion—Infestation—Etoposide—brain cancer	0.000174	0.00121	CcSEcCtD
Bupropion—Thrombocytopenia—Hydroxyurea—brain cancer	0.000174	0.00121	CcSEcCtD
Bupropion—CYP2E1—head—brain cancer	0.000173	0.00864	CbGeAlD
Bupropion—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000172	0.0012	CcSEcCtD
Bupropion—Alopecia—Temozolomide—brain cancer	0.000172	0.0012	CcSEcCtD
Bupropion—Skin disorder—Hydroxyurea—brain cancer	0.000172	0.0012	CcSEcCtD
Bupropion—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000172	0.00521	CbGpPWpGaD
Bupropion—Acute coronary syndrome—Etoposide—brain cancer	0.000171	0.00119	CcSEcCtD
Bupropion—Mental disorder—Temozolomide—brain cancer	0.000171	0.00119	CcSEcCtD
Bupropion—Neuropathy peripheral—Etoposide—brain cancer	0.00017	0.00119	CcSEcCtD
Bupropion—Myocardial infarction—Etoposide—brain cancer	0.00017	0.00119	CcSEcCtD
Bupropion—Back pain—Carmustine—brain cancer	0.00017	0.00118	CcSEcCtD
Bupropion—Malnutrition—Temozolomide—brain cancer	0.00017	0.00118	CcSEcCtD
Bupropion—Jaundice—Etoposide—brain cancer	0.000169	0.00118	CcSEcCtD
Bupropion—Stomatitis—Etoposide—brain cancer	0.000169	0.00118	CcSEcCtD
Bupropion—Anorexia—Hydroxyurea—brain cancer	0.000169	0.00118	CcSEcCtD
Bupropion—Hypersensitivity—Procarbazine—brain cancer	0.000169	0.00117	CcSEcCtD
Bupropion—CYP2B6—central nervous system—brain cancer	0.000168	0.00841	CbGeAlD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000167	0.00507	CbGpPWpGaD
Bupropion—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000167	0.00505	CbGpPWpGaD
Bupropion—Dysgeusia—Temozolomide—brain cancer	0.000166	0.00116	CcSEcCtD
Bupropion—Vision blurred—Carmustine—brain cancer	0.000166	0.00115	CcSEcCtD
Bupropion—Tremor—Carmustine—brain cancer	0.000165	0.00115	CcSEcCtD
Bupropion—Asthenia—Procarbazine—brain cancer	0.000164	0.00114	CcSEcCtD
Bupropion—Back pain—Temozolomide—brain cancer	0.000164	0.00114	CcSEcCtD
Bupropion—Anaemia—Carmustine—brain cancer	0.000162	0.00113	CcSEcCtD
Bupropion—Pruritus—Procarbazine—brain cancer	0.000162	0.00113	CcSEcCtD
Bupropion—Agitation—Carmustine—brain cancer	0.000161	0.00112	CcSEcCtD
Bupropion—Vision blurred—Temozolomide—brain cancer	0.00016	0.00111	CcSEcCtD
Bupropion—Tremor—Temozolomide—brain cancer	0.000159	0.00111	CcSEcCtD
Bupropion—Dyspnoea—Hydroxyurea—brain cancer	0.000158	0.0011	CcSEcCtD
Bupropion—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000158	0.00479	CbGpPWpGaD
Bupropion—CYP2E1—central nervous system—brain cancer	0.000158	0.00789	CbGeAlD
Bupropion—Somnolence—Hydroxyurea—brain cancer	0.000158	0.0011	CcSEcCtD
Bupropion—Ill-defined disorder—Temozolomide—brain cancer	0.000157	0.0011	CcSEcCtD
Bupropion—Leukopenia—Carmustine—brain cancer	0.000157	0.00109	CcSEcCtD
Bupropion—Anaemia—Temozolomide—brain cancer	0.000157	0.00109	CcSEcCtD
Bupropion—Diarrhoea—Procarbazine—brain cancer	0.000157	0.00109	CcSEcCtD
Bupropion—Dyspepsia—Hydroxyurea—brain cancer	0.000156	0.00109	CcSEcCtD
Bupropion—Agitation—Temozolomide—brain cancer	0.000156	0.00109	CcSEcCtD
Bupropion—Hypoaesthesia—Etoposide—brain cancer	0.000155	0.00108	CcSEcCtD
Bupropion—Angioedema—Temozolomide—brain cancer	0.000155	0.00108	CcSEcCtD
Bupropion—Decreased appetite—Hydroxyurea—brain cancer	0.000154	0.00107	CcSEcCtD
Bupropion—CYP2E1—cerebellum—brain cancer	0.000154	0.00771	CbGeAlD
Bupropion—Urinary tract disorder—Etoposide—brain cancer	0.000154	0.00107	CcSEcCtD
Bupropion—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000153	0.00107	CcSEcCtD
Bupropion—Malaise—Temozolomide—brain cancer	0.000153	0.00107	CcSEcCtD
Bupropion—Urethral disorder—Etoposide—brain cancer	0.000153	0.00106	CcSEcCtD
Bupropion—Fatigue—Hydroxyurea—brain cancer	0.000153	0.00106	CcSEcCtD
Bupropion—Vertigo—Temozolomide—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Convulsion—Carmustine—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Leukopenia—Temozolomide—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Hypertension—Carmustine—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Pain—Hydroxyurea—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Constipation—Hydroxyurea—brain cancer	0.000152	0.00106	CcSEcCtD
Bupropion—Dizziness—Procarbazine—brain cancer	0.000152	0.00105	CcSEcCtD
Bupropion—Palpitations—Temozolomide—brain cancer	0.00015	0.00104	CcSEcCtD
Bupropion—Myalgia—Carmustine—brain cancer	0.00015	0.00104	CcSEcCtD
Bupropion—Chest pain—Carmustine—brain cancer	0.00015	0.00104	CcSEcCtD
Bupropion—Anxiety—Carmustine—brain cancer	0.000149	0.00104	CcSEcCtD
Bupropion—CYP2C8—brain—brain cancer	0.000149	0.00744	CbGeAlD
Bupropion—Cough—Temozolomide—brain cancer	0.000148	0.00103	CcSEcCtD
Bupropion—Erythema multiforme—Etoposide—brain cancer	0.000148	0.00103	CcSEcCtD
Bupropion—Convulsion—Temozolomide—brain cancer	0.000147	0.00102	CcSEcCtD
Bupropion—Hypertension—Temozolomide—brain cancer	0.000147	0.00102	CcSEcCtD
Bupropion—Feeling abnormal—Hydroxyurea—brain cancer	0.000146	0.00102	CcSEcCtD
Bupropion—Eye disorder—Etoposide—brain cancer	0.000146	0.00101	CcSEcCtD
Bupropion—Vomiting—Procarbazine—brain cancer	0.000146	0.00101	CcSEcCtD
Bupropion—Flushing—Etoposide—brain cancer	0.000145	0.00101	CcSEcCtD
Bupropion—Cardiac disorder—Etoposide—brain cancer	0.000145	0.00101	CcSEcCtD
Bupropion—Confusional state—Carmustine—brain cancer	0.000145	0.00101	CcSEcCtD
Bupropion—Arthralgia—Temozolomide—brain cancer	0.000144	0.00101	CcSEcCtD
Bupropion—Myalgia—Temozolomide—brain cancer	0.000144	0.00101	CcSEcCtD
Bupropion—Rash—Procarbazine—brain cancer	0.000144	0.00101	CcSEcCtD
Bupropion—Dermatitis—Procarbazine—brain cancer	0.000144	0.001	CcSEcCtD
Bupropion—Anxiety—Temozolomide—brain cancer	0.000144	0.001	CcSEcCtD
Bupropion—Headache—Procarbazine—brain cancer	0.000144	0.000999	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000144	0.000999	CcSEcCtD
Bupropion—Oedema—Carmustine—brain cancer	0.000143	0.000998	CcSEcCtD
Bupropion—Discomfort—Temozolomide—brain cancer	0.000143	0.000994	CcSEcCtD
Bupropion—Infection—Carmustine—brain cancer	0.000142	0.000991	CcSEcCtD
Bupropion—Angiopathy—Etoposide—brain cancer	0.000142	0.000985	CcSEcCtD
Bupropion—Dry mouth—Temozolomide—brain cancer	0.000141	0.000984	CcSEcCtD
Bupropion—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000141	0.00428	CbGpPWpGaD
Bupropion—Immune system disorder—Etoposide—brain cancer	0.000141	0.000981	CcSEcCtD
Bupropion—CYP3A4—endocrine gland—brain cancer	0.000141	0.00705	CbGeAlD
Bupropion—Mediastinal disorder—Etoposide—brain cancer	0.000141	0.000979	CcSEcCtD
Bupropion—Thrombocytopenia—Carmustine—brain cancer	0.00014	0.000977	CcSEcCtD
Bupropion—Body temperature increased—Hydroxyurea—brain cancer	0.00014	0.000976	CcSEcCtD
Bupropion—Chills—Etoposide—brain cancer	0.00014	0.000974	CcSEcCtD
Bupropion—Tachycardia—Carmustine—brain cancer	0.00014	0.000974	CcSEcCtD
Bupropion—Confusional state—Temozolomide—brain cancer	0.00014	0.000972	CcSEcCtD
Bupropion—Oedema—Temozolomide—brain cancer	0.000139	0.000964	CcSEcCtD
Bupropion—Anaphylactic shock—Temozolomide—brain cancer	0.000139	0.000964	CcSEcCtD
Bupropion—CYP2D6—endocrine gland—brain cancer	0.000139	0.00693	CbGeAlD
Bupropion—Alopecia—Etoposide—brain cancer	0.000138	0.00096	CcSEcCtD
Bupropion—Infection—Temozolomide—brain cancer	0.000138	0.000958	CcSEcCtD
Bupropion—CYP2D6—head—brain cancer	0.000137	0.00684	CbGeAlD
Bupropion—Anorexia—Carmustine—brain cancer	0.000137	0.000951	CcSEcCtD
Bupropion—Nausea—Procarbazine—brain cancer	0.000136	0.000947	CcSEcCtD
Bupropion—Nervous system disorder—Temozolomide—brain cancer	0.000136	0.000946	CcSEcCtD
Bupropion—Thrombocytopenia—Temozolomide—brain cancer	0.000136	0.000944	CcSEcCtD
Bupropion—Skin disorder—Temozolomide—brain cancer	0.000135	0.000937	CcSEcCtD
Bupropion—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000134	0.00408	CbGpPWpGaD
Bupropion—Hypotension—Carmustine—brain cancer	0.000134	0.000932	CcSEcCtD
Bupropion—Hyperhidrosis—Temozolomide—brain cancer	0.000134	0.000932	CcSEcCtD
Bupropion—CYP2B6—brain—brain cancer	0.000133	0.00668	CbGeAlD
Bupropion—Dysgeusia—Etoposide—brain cancer	0.000133	0.000926	CcSEcCtD
Bupropion—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000133	0.00402	CbGpPWpGaD
Bupropion—Anorexia—Temozolomide—brain cancer	0.000132	0.000919	CcSEcCtD
Bupropion—Back pain—Etoposide—brain cancer	0.000131	0.000914	CcSEcCtD
Bupropion—Hypersensitivity—Hydroxyurea—brain cancer	0.000131	0.000909	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Carmustine—brain cancer	0.000131	0.000909	CcSEcCtD
Bupropion—Muscle spasms—Etoposide—brain cancer	0.000131	0.000909	CcSEcCtD
Bupropion—Insomnia—Carmustine—brain cancer	0.00013	0.000902	CcSEcCtD
Bupropion—Paraesthesia—Carmustine—brain cancer	0.000129	0.000896	CcSEcCtD
Bupropion—Dyspnoea—Carmustine—brain cancer	0.000128	0.00089	CcSEcCtD
Bupropion—Somnolence—Carmustine—brain cancer	0.000127	0.000887	CcSEcCtD
Bupropion—CYP2B6—Biological oxidations—CYP2C9—brain cancer	0.000127	0.00386	CbGpPWpGaD
Bupropion—Asthenia—Hydroxyurea—brain cancer	0.000127	0.000886	CcSEcCtD
Bupropion—CYP3A4—central nervous system—brain cancer	0.000127	0.00635	CbGeAlD
Bupropion—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000126	0.000878	CcSEcCtD
Bupropion—Ill-defined disorder—Etoposide—brain cancer	0.000126	0.000877	CcSEcCtD
Bupropion—CYP2B6—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00381	CbGpPWpGaD
Bupropion—Anaemia—Etoposide—brain cancer	0.000126	0.000874	CcSEcCtD
Bupropion—Insomnia—Temozolomide—brain cancer	0.000125	0.000872	CcSEcCtD
Bupropion—CYP2E1—brain—brain cancer	0.000125	0.00626	CbGeAlD
Bupropion—CYP2D6—central nervous system—brain cancer	0.000125	0.00625	CbGeAlD
Bupropion—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000125	0.00378	CbGpPWpGaD
Bupropion—Decreased appetite—Carmustine—brain cancer	0.000125	0.000867	CcSEcCtD
Bupropion—Paraesthesia—Temozolomide—brain cancer	0.000124	0.000866	CcSEcCtD
Bupropion—Gastrointestinal disorder—Carmustine—brain cancer	0.000124	0.000861	CcSEcCtD
Bupropion—Dyspnoea—Temozolomide—brain cancer	0.000123	0.00086	CcSEcCtD
Bupropion—Somnolence—Temozolomide—brain cancer	0.000123	0.000857	CcSEcCtD
Bupropion—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000123	0.00373	CbGpPWpGaD
Bupropion—Pain—Carmustine—brain cancer	0.000123	0.000853	CcSEcCtD
Bupropion—Constipation—Carmustine—brain cancer	0.000123	0.000853	CcSEcCtD
Bupropion—Malaise—Etoposide—brain cancer	0.000122	0.000853	CcSEcCtD
Bupropion—Vertigo—Etoposide—brain cancer	0.000122	0.000849	CcSEcCtD
Bupropion—CYP2D6—cerebellum—brain cancer	0.000122	0.00611	CbGeAlD
Bupropion—Dyspepsia—Temozolomide—brain cancer	0.000122	0.000849	CcSEcCtD
Bupropion—Leukopenia—Etoposide—brain cancer	0.000122	0.000846	CcSEcCtD
Bupropion—Diarrhoea—Hydroxyurea—brain cancer	0.000121	0.000844	CcSEcCtD
Bupropion—Decreased appetite—Temozolomide—brain cancer	0.00012	0.000838	CcSEcCtD
Bupropion—SLC6A3—Dopaminergic Neurogenesis—STAT3—brain cancer	0.00012	0.00364	CbGpPWpGaD
Bupropion—Gastrointestinal disorder—Temozolomide—brain cancer	0.00012	0.000832	CcSEcCtD
Bupropion—Fatigue—Temozolomide—brain cancer	0.000119	0.000831	CcSEcCtD
Bupropion—Loss of consciousness—Etoposide—brain cancer	0.000119	0.000831	CcSEcCtD
Bupropion—Cough—Etoposide—brain cancer	0.000119	0.000825	CcSEcCtD
Bupropion—Constipation—Temozolomide—brain cancer	0.000118	0.000825	CcSEcCtD
Bupropion—Pain—Temozolomide—brain cancer	0.000118	0.000825	CcSEcCtD
Bupropion—Feeling abnormal—Carmustine—brain cancer	0.000118	0.000822	CcSEcCtD
Bupropion—Convulsion—Etoposide—brain cancer	0.000118	0.000819	CcSEcCtD
Bupropion—Hypertension—Etoposide—brain cancer	0.000117	0.000816	CcSEcCtD
Bupropion—Dizziness—Hydroxyurea—brain cancer	0.000117	0.000816	CcSEcCtD
Bupropion—Gastrointestinal pain—Carmustine—brain cancer	0.000117	0.000816	CcSEcCtD
Bupropion—Chest pain—Etoposide—brain cancer	0.000116	0.000805	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000115	0.000799	CcSEcCtD
Bupropion—Discomfort—Etoposide—brain cancer	0.000114	0.000795	CcSEcCtD
Bupropion—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000114	0.00346	CbGpPWpGaD
Bupropion—Feeling abnormal—Temozolomide—brain cancer	0.000114	0.000795	CcSEcCtD
Bupropion—Abdominal pain—Carmustine—brain cancer	0.000113	0.000789	CcSEcCtD
Bupropion—Body temperature increased—Carmustine—brain cancer	0.000113	0.000789	CcSEcCtD
Bupropion—Gastrointestinal pain—Temozolomide—brain cancer	0.000113	0.000788	CcSEcCtD
Bupropion—Vomiting—Hydroxyurea—brain cancer	0.000113	0.000785	CcSEcCtD
Bupropion—Rash—Hydroxyurea—brain cancer	0.000112	0.000778	CcSEcCtD
Bupropion—Confusional state—Etoposide—brain cancer	0.000112	0.000778	CcSEcCtD
Bupropion—Dermatitis—Hydroxyurea—brain cancer	0.000112	0.000777	CcSEcCtD
Bupropion—Headache—Hydroxyurea—brain cancer	0.000111	0.000773	CcSEcCtD
Bupropion—Anaphylactic shock—Etoposide—brain cancer	0.000111	0.000772	CcSEcCtD
Bupropion—Infection—Etoposide—brain cancer	0.00011	0.000766	CcSEcCtD
Bupropion—Urticaria—Temozolomide—brain cancer	0.00011	0.000766	CcSEcCtD
Bupropion—Body temperature increased—Temozolomide—brain cancer	0.00011	0.000762	CcSEcCtD
Bupropion—Abdominal pain—Temozolomide—brain cancer	0.00011	0.000762	CcSEcCtD
Bupropion—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000109	0.0033	CbGpPWpGaD
Bupropion—Thrombocytopenia—Etoposide—brain cancer	0.000109	0.000755	CcSEcCtD
Bupropion—Tachycardia—Etoposide—brain cancer	0.000108	0.000753	CcSEcCtD
Bupropion—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000108	0.00327	CbGpPWpGaD
Bupropion—Skin disorder—Etoposide—brain cancer	0.000108	0.000749	CcSEcCtD
Bupropion—Hyperhidrosis—Etoposide—brain cancer	0.000107	0.000746	CcSEcCtD
Bupropion—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000106	0.00323	CbGpPWpGaD
Bupropion—Anorexia—Etoposide—brain cancer	0.000106	0.000735	CcSEcCtD
Bupropion—Hypersensitivity—Carmustine—brain cancer	0.000106	0.000735	CcSEcCtD
Bupropion—Nausea—Hydroxyurea—brain cancer	0.000105	0.000733	CcSEcCtD
Bupropion—Hypotension—Etoposide—brain cancer	0.000104	0.000721	CcSEcCtD
Bupropion—Asthenia—Carmustine—brain cancer	0.000103	0.000716	CcSEcCtD
Bupropion—Hypersensitivity—Temozolomide—brain cancer	0.000102	0.00071	CcSEcCtD
Bupropion—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000101	0.00307	CbGpPWpGaD
Bupropion—Paraesthesia—Etoposide—brain cancer	9.95e-05	0.000693	CcSEcCtD
Bupropion—Asthenia—Temozolomide—brain cancer	9.94e-05	0.000692	CcSEcCtD
Bupropion—CYP2D6—brain—brain cancer	9.91e-05	0.00496	CbGeAlD
Bupropion—Dyspnoea—Etoposide—brain cancer	9.88e-05	0.000688	CcSEcCtD
Bupropion—Somnolence—Etoposide—brain cancer	9.85e-05	0.000686	CcSEcCtD
Bupropion—Diarrhoea—Carmustine—brain cancer	9.81e-05	0.000683	CcSEcCtD
Bupropion—Pruritus—Temozolomide—brain cancer	9.8e-05	0.000682	CcSEcCtD
Bupropion—Decreased appetite—Etoposide—brain cancer	9.64e-05	0.000671	CcSEcCtD
Bupropion—Gastrointestinal disorder—Etoposide—brain cancer	9.57e-05	0.000666	CcSEcCtD
Bupropion—Fatigue—Etoposide—brain cancer	9.56e-05	0.000665	CcSEcCtD
Bupropion—Dizziness—Carmustine—brain cancer	9.48e-05	0.00066	CcSEcCtD
Bupropion—Constipation—Etoposide—brain cancer	9.48e-05	0.00066	CcSEcCtD
Bupropion—Pain—Etoposide—brain cancer	9.48e-05	0.00066	CcSEcCtD
Bupropion—Diarrhoea—Temozolomide—brain cancer	9.48e-05	0.00066	CcSEcCtD
Bupropion—SLC6A2—Transmembrane transport of small molecules—S100A10—brain cancer	9.4e-05	0.00285	CbGpPWpGaD
Bupropion—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	9.29e-05	0.00282	CbGpPWpGaD
Bupropion—Dizziness—Temozolomide—brain cancer	9.16e-05	0.000638	CcSEcCtD
Bupropion—Feeling abnormal—Etoposide—brain cancer	9.13e-05	0.000636	CcSEcCtD
Bupropion—Vomiting—Carmustine—brain cancer	9.11e-05	0.000634	CcSEcCtD
Bupropion—Gastrointestinal pain—Etoposide—brain cancer	9.06e-05	0.000631	CcSEcCtD
Bupropion—Rash—Carmustine—brain cancer	9.04e-05	0.000629	CcSEcCtD
Bupropion—Dermatitis—Carmustine—brain cancer	9.03e-05	0.000628	CcSEcCtD
Bupropion—Headache—Carmustine—brain cancer	8.98e-05	0.000625	CcSEcCtD
Bupropion—CYP2D6—Biological oxidations—CYP2C9—brain cancer	8.85e-05	0.00268	CbGpPWpGaD
Bupropion—Vomiting—Temozolomide—brain cancer	8.81e-05	0.000613	CcSEcCtD
Bupropion—Urticaria—Etoposide—brain cancer	8.81e-05	0.000613	CcSEcCtD
Bupropion—Body temperature increased—Etoposide—brain cancer	8.76e-05	0.00061	CcSEcCtD
Bupropion—Abdominal pain—Etoposide—brain cancer	8.76e-05	0.00061	CcSEcCtD
Bupropion—Rash—Temozolomide—brain cancer	8.73e-05	0.000608	CcSEcCtD
Bupropion—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	8.73e-05	0.00265	CbGpPWpGaD
Bupropion—Dermatitis—Temozolomide—brain cancer	8.73e-05	0.000607	CcSEcCtD
Bupropion—Headache—Temozolomide—brain cancer	8.68e-05	0.000604	CcSEcCtD
Bupropion—Nausea—Carmustine—brain cancer	8.51e-05	0.000593	CcSEcCtD
Bupropion—SLC6A3—Transmembrane transport of small molecules—S100A10—brain cancer	8.33e-05	0.00253	CbGpPWpGaD
Bupropion—Nausea—Temozolomide—brain cancer	8.23e-05	0.000573	CcSEcCtD
Bupropion—Hypersensitivity—Etoposide—brain cancer	8.17e-05	0.000568	CcSEcCtD
Bupropion—Asthenia—Etoposide—brain cancer	7.95e-05	0.000554	CcSEcCtD
Bupropion—Pruritus—Etoposide—brain cancer	7.84e-05	0.000546	CcSEcCtD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	7.74e-05	0.00235	CbGpPWpGaD
Bupropion—Diarrhoea—Etoposide—brain cancer	7.58e-05	0.000528	CcSEcCtD
Bupropion—CYP1A2—Biological oxidations—CYP2C9—brain cancer	7.5e-05	0.00227	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	7.4e-05	0.00224	CbGpPWpGaD
Bupropion—Dizziness—Etoposide—brain cancer	7.33e-05	0.00051	CcSEcCtD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	7.09e-05	0.00215	CbGpPWpGaD
Bupropion—Vomiting—Etoposide—brain cancer	7.05e-05	0.000491	CcSEcCtD
Bupropion—Rash—Etoposide—brain cancer	6.99e-05	0.000486	CcSEcCtD
Bupropion—Dermatitis—Etoposide—brain cancer	6.98e-05	0.000486	CcSEcCtD
Bupropion—Headache—Etoposide—brain cancer	6.94e-05	0.000483	CcSEcCtD
Bupropion—Nausea—Etoposide—brain cancer	6.58e-05	0.000458	CcSEcCtD
Bupropion—CYP3A4—Biological oxidations—CYP2C9—brain cancer	5.79e-05	0.00176	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	5.71e-05	0.00173	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	4.46e-05	0.00135	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—TRPC6—brain cancer	4.34e-05	0.00132	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	4.14e-05	0.00126	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	4.02e-05	0.00122	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—TRPC6—brain cancer	3.85e-05	0.00117	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	3.42e-05	0.00104	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	3.14e-05	0.000953	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	3.07e-05	0.000932	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	3.07e-05	0.000932	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	3.03e-05	0.000918	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	2.88e-05	0.000873	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CYP2C9—brain cancer	2.7e-05	0.000819	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.46e-05	0.000747	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—BSG—brain cancer	2.3e-05	0.000696	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CYP2C9—brain cancer	2.18e-05	0.000661	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CYP2C9—brain cancer	2.13e-05	0.000647	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	2.11e-05	0.000639	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—IDH1—brain cancer	1.97e-05	0.000599	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—BSG—brain cancer	1.85e-05	0.000562	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CYP2C9—brain cancer	1.84e-05	0.000559	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—BSG—brain cancer	1.81e-05	0.00055	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—IDH1—brain cancer	1.59e-05	0.000483	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—BSG—brain cancer	1.57e-05	0.000475	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—ENO2—brain cancer	1.56e-05	0.000473	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—IDH1—brain cancer	1.56e-05	0.000473	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CYP2C9—brain cancer	1.51e-05	0.000459	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—IDH1—brain cancer	1.35e-05	0.000409	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—BSG—brain cancer	1.29e-05	0.00039	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CYP2C9—brain cancer	1.28e-05	0.000389	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—BSG—brain cancer	1.28e-05	0.000387	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—ENO2—brain cancer	1.26e-05	0.000382	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—ENO2—brain cancer	1.23e-05	0.000374	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—IDH1—brain cancer	1.11e-05	0.000336	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.1e-05	0.000333	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—IDH1—brain cancer	1.1e-05	0.000333	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—BSG—brain cancer	1.09e-05	0.000331	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—ENO2—brain cancer	1.07e-05	0.000323	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CYP2C9—brain cancer	9.9e-06	0.0003	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—IDH1—brain cancer	9.38e-06	0.000284	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	8.94e-06	0.000271	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—ENO2—brain cancer	8.75e-06	0.000265	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—ENO2—brain cancer	8.67e-06	0.000263	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—BSG—brain cancer	8.42e-06	0.000255	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	7.64e-06	0.000232	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—ENO2—brain cancer	7.41e-06	0.000225	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—IDH1—brain cancer	7.24e-06	0.000219	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PIK3CG—brain cancer	7.16e-06	0.000217	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PIK3CG—brain cancer	5.78e-06	0.000175	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—ENO2—brain cancer	5.72e-06	0.000173	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PIK3CG—brain cancer	5.66e-06	0.000172	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PIK3CG—brain cancer	4.89e-06	0.000148	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PIK3CG—brain cancer	4.01e-06	0.000122	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PIK3CG—brain cancer	3.98e-06	0.000121	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PIK3CG—brain cancer	3.4e-06	0.000103	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PIK3CG—brain cancer	2.62e-06	7.96e-05	CbGpPWpGaD
